Search Within

Charlotte Eielson Ariyan

  1. "Sarcoma Service"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (4)
  3. Research Letter (1)
Groups
  1. Department of Medicine (11)
  2. Melanoma Disease Management Team (11)
  3. Sarcoma Service (11)
  4. Solid Tumor Oncology Division (11)
  5. Surgery (11)
  6. Hematologic Malignancies, Division of (10)

More Groups

People
  1. Sandra D'Angelo (10)
  2. Ciara Kelly (7)
  3. Cristina Antonescu (6)
  4. Samuel Singer (6)
  5. William Tap (6)
  6. Aimee Crago (5)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2021 (1)
  4. 2020 (1)
  5. 2019 (2)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Annals of Oncology (1)
  3. Annals of Surgical Oncology (1)
  4. Frontiers in Oncology (1)
  5. JAMA Oncology (1)
  6. Nature (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Nature Publishing Group (2)
  3. American Medical Association (1)
  4. Elsevier Inc. (1)
  5. Frontiers Media S.A. (1)
  6. Oxford University Press (1)

More Publishers

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An open label phase IIa study evaluating the preliminary efficacy of intratumoural tigilanol tiglate (TT) in advanced and/or metastatic soft tissue sarcoma (STS)
    Meeting Abstract

    Bartlett, E. K.; Li, D.; Shemla, S.; Ariyan, C. E.; Dickinson, S.; Crago, A.; Li, G.; Agaram, N.; D'Angelo, S. P.; Maki, R. G.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Journal Article

    Barker, C. A.; D'Angelo, S. P.; Wasilewski, G.; Steckler, A. M.; Lian, M.; Zhang, Z.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Interim results of a phase II trial of regional melphalan via limb infusion and systemic PD1 blockade in patients with extremity sarcoma
    Meeting Abstract

    Bartlett, E. K.; D'Angelo, S.; Kelly, C.; Rosenbaum, E.; Movva, S.; Erinjeri, J.; Fisher, C.; Singer, S.; Antonescu, C.; Ariyan, C.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II randomized trial of talimogene laherparepvec (T-VEC) oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Meeting Abstract

    Barker, C. A.; D'Angelo, S. P.; Steckler, A. M.; Lian, M.; Wasilewski, G.; Lacouture, M. E.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Case report: Response to regional melphalan via limb infusion and systemic PD1 blockade in recurrent myxofibrosarcoma: A report of 2 cases
    Journal Article

    Bartlett, E. K.; D’Angelo, S. P.; Kelly, C. M.; Siegelbaum, R. H.; Fisher, C.; Antonescu, C. R.; Ariyan, C. E.
    Frontiers in Oncology (2021)

    Fulltext@MSK | Save
  • Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial
    Journal Article

    Kelly, C. M.; Antonescu, C. R.; Bowler, T.; Munhoz, R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Dholakia, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Kelly, C. M.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Qin, L. X.; Adamson, T.; Condy, M. M.; Biniakewitz, M.; Phelan, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; Munhoz, R. R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Dholakia, R.; Condy, M. M.; Singer, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save